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http://dx.doi.org/10.1016/j.stemcr.2017.01.017SUMMARYAlthough human induced pluripotent stem cells (hiPSCs) hold great potential for the study of human diseases affecting disparate cell
types, they have been underutilized in seeking mechanistic insights into the pathogenesis of congenital craniofacial disorders. Cranio-
frontonasal syndrome (CFNS) is a rare X-linked disorder caused by mutations in EFNB1 and characterized by craniofacial, skeletal,
and neurological anomalies. Heterozygous females are more severely affected than hemizygous males, a phenomenon termed cellular
interference that involves mosaicism for EPHRIN-B1 function. Although the mechanistic basis for cellular interference in CFNS has
been hypothesized to involve Eph/ephrin-mediated cell segregation, no direct evidence for this has been demonstrated. Here, by
generating hiPSCs from CFNS patients, we demonstrate that mosaicism for EPHRIN-B1 expression induced by random X inactivation
in heterozygous females results in robust cell segregation in human neuroepithelial cells, thus supplying experimental evidence that
Eph/ephrin-mediated cell segregation is relevant to pathogenesis in human CFNS patients.INTRODUCTION
Congenital craniofacial disorders represent over one-third
of all birth defects (Global strategies to reduce the health
care burden of craniofacial anomalies, 2004). While the
genetic causes of many syndromes are known, how these
mutations lead to abnormal cellular mechanisms under-
lying these disorders is incompletely understood. A better
understanding of the underlying etiology of these disorders
is needed to develop new treatment strategies targeted to
the cellular and molecular basis of disease. The emergence
of human induced pluripotent stem cells (hiPSCs) as a tool
for human disease modeling (Takahashi et al., 2007; Taka-
hashi and Yamanaka, 2006; Tiscornia et al., 2011; Yu
et al., 2007) holds great promise for improving our cellular
understanding of craniofacial diseases, as hiPSCs can be
differentiated into patient-specific, disease-relevant cell
types. However, perhaps due to the challenge of modeling
structural aspects of craniofacial disease in two dimensions
in cell culture, hiPSC models for these disorders are not yet
widely used.
Craniofrontonasal syndrome (CFNS; OMIM no. 304110)
is an X-linked disorder caused by mutations in EFNB1 and
characterized by craniofacial, skeletal, and neurological
anomalies (Twigg et al., 2004; Wieland et al., 2004). TheStem Ce
This is an open access article under the Cmost common clinical findings include hypertelorism,
frontonasal dysplasia, coronal synostosis, bifid nasal tip,
longitudinal splitting of the nails, and wiry or frizzy hair;
other less frequent symptoms include cleft lip and palate,
diaphragmatic hernia, agenesis of the corpus callosum,
syndactyly, and polydactyly (Twigg et al., 2004, 2006,
2013; Wieacker and Wieland, 2005; Wieland et al., 2004).
CFNS is an unusual X-linked disorder in that heterozygous
females are more severely affected than hemizygous male
patients, who are usually unaffected or mildly affected
and often present only with hypertelorism (Wieacker and
Wieland, 2005). This counterintuitive inversion of severity
has been termed cellular interference, a phenomenon
whereby randomX chromosome inactivation (XCI) in het-
erozygous female CFNS patients results in mosaicism for
EFNB1 expression, leading to abnormal cellular interac-
tions (Twigg et al., 2013; Wieacker and Wieland, 2005).
Consistent with this notion, rare severely affected male
CFNS patients have somatic mosaic mutations in EFNB1
(Twigg et al., 2013), reinforcingmosaicism as an important
aspect of CFNS pathogenesis.
EFNB1 encodes EPHRIN-B1, a member of the Eph/ephrin
family of membrane-linked signaling molecules, and
abnormal signaling between cells expressing wild-type
EPHRIN-B1 and cells that are functionally EPHRIN-B1-nullll Reports j Vol. 8 j 529–537 j March 14, 2017 j ª 2017 The Authors. 529
C BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
may occur in the mosaic state (Compagni et al., 2003;
Wieacker and Wieland, 2005). During development, Eph/
ephrin signaling plays an important role in boundary
formation, an essential process that requires signaling
between adjacent cells and often involves segregation be-
tween different cell types (Batlle and Wilkinson, 2012;
Cayuso et al., 2015; Fagotto, 2014; Fagotto et al., 2014).
Differential expression of Eph receptors and ephrins in vivo
can restrict cell intermingling in the vertebrate hindbrain
(Xu et al., 1999), limb bud (Compagni et al., 2003; Davy
et al., 2004), eye (Cavodeassi et al., 2013), somites (Barrios
et al., 2003; Durbin et al., 1998), cranial sutures (Merrill
et al., 2006; Ting et al., 2009), and intestinal crypts (Holm-
berg et al., 2006), as well as in the Drosophila wing disc
(Umetsu et al., 2014). In culture, expressing an Eph receptor
in one population of cells and an ephrin in another restricts
intermingling of cells from the two populations (Jorgensen
et al., 2009; Mellitzer et al., 1999; Poliakov et al., 2008).
Further, cell segregation occurs in developing Efnb1+/
mouse limb (Compagni et al., 2003) and secondary palate
(Bush and Soriano, 2010), supporting the idea that XCI-
induced mosaicism leads to segregation of Ephrin-B1 ex-
pressing and non-expressing cells.
The role of Eph/ephrin signaling in boundary formation
and supporting data from mouse models suggest that
mosaicism for EPHRIN-B1 expression may lead to aberrant
cell segregation in human CFNS patients (Compagni et al.,
2003; Twigg et al., 2004, 2006, 2013; Wieacker and Wie-
land, 2005; Wieland et al., 2004). However, it has proven
difficult to determine the mechanism of cellular inter-
ference, and EPHRIN-B1-mediated cell segregation has
not been demonstrated in CFNS patients. Here, we report
the generation of an hiPSC model to study defects in
morphogenesis in a congenital craniofacial disorder. We
demonstrate that cell segregation is a consequence of
EPHRIN-B1 mosaicism in CFNS, providing evidence that
this cell behavior is relevant to CFNS pathogenesis in
humans. The CFNS hiPSC model provides proof of princi-
ple that hiPSC-derived cell types can be used both tomodel
structural anomalies and to gain valuable insights into
fundamental cellular mechanisms of morphogenesis in
patient cells.RESULTS
Isolation of CFNS Human Dermal Fibroblasts and
Reprogramming to hiPSCs
To investigate cellularmechanisms of CFNS, we established
human dermal fibroblast (HDF) cultures from a female
CFNS patient with a heterozygous mutation in exon 5
of EFNB1 (EFNB1+/c.712delG) (Byrne et al., 2009; Hogue
et al., 2010). We also established HDF cultures from skin530 Stem Cell Reports j Vol. 8 j 529–537 j March 14, 2017biopsies of the patient’s father, a hemizygous carrier of
themutation (EFNB1Y/c.712delG), and her unaffectedmother
(EFNB1+/+). We generated hiPSC lines from low-passage
HDFs of each individual using non-integrating episomal
vectors (Bershteyn et al., 2014; Okita et al., 2011) and
selected three hiPSC lines from each individual for further
analysis and experimentation (from the patient, lines
CFNShet-1, -2, and -3; from the patient’s father, lines
CFNShemi-1, -2, and -3; and from the patient’s mother,
lines wt-1, -2, and -3). Sequencing of exon 5 of EFNB1
confirmed the expected genotypes (Figures 1A and S1A).
All nine hiPSC lines were free of reprogramming plasmid
integration by PCR (data not shown) and had normal
G-banded karyotypes (Figure S1B).
Characterization of CFNS hiPSC Pluripotency and
Differentiation Potential
CFNShet and CFNShemi HDFs were reprogrammed to
generate hiPSCs that possessed embryonic stem cell-like
morphology similar to that of wild-type hiPSCs. All lines,
regardless of genotype, possessed differentiation potential
to ectoderm (bIII-tubulin), endoderm (a-fetoprotein), and
mesoderm (muscle actin) in an embryoid body protocol
(Figures 1B and S1C) and expressed the endogenous plurip-
otencymarkers OCT4, SOX2, NANOG, TRA-1-60, and TRA-
1-81 (Figures 1C and S1D).
XCI-induced mosaicism in females plays a central role in
CFNS (Twigg et al., 2004, 2006, 2013; Wieacker and Wie-
land, 2005; Wieland et al., 2004). However, XCI status of
female hiPSCs can vary across different lines (Lessing
et al., 2013), depending on conditions used for reprogram-
ming (Tchieu et al., 2010; Tomoda et al., 2012;Wutz, 2012).
To model CFNS, we used reprogramming conditions
that favor maintenance of XCI rather than X reactivation
(Wutz, 2012) and characterized XCI status of CFNShet
HDFs and each CFNShet hiPSC line using the human
androgen receptor assay (HUMARA) (Kiedrowski et al.,
2011). CFNShet HDFs showed an expected XCI ratio close
to 50%, as in earlier studies that indicated no skewed X
inactivation in female CFNS patients (Table S1) (Twigg
et al., 2004; Wieland et al., 2004, 2007). All three CFNShet
hiPSC lines showed complete inactivation of the maternal,
wild-type X chromosome, consistent with the clonal XCI
expected from female hiPSC lines derived from a single
fibroblast under conditions that favor XCI maintenance
(Tchieu et al., 2010). Therefore, only the paternal, mutant
copy of EFNB1 is expressed in these lines (Table S1), and
they are not expected to express functional EPHRIN-B1.
Differentiation and Characterization of CFNS
Neuroepithelial Cells
CFNS affects multiple structures derived from neural crest
cells (NCCs), a multipotent population of stem cells that
Figure 1. Reprogramming of Wild-Type,
CFNShet, and CFNShemi HDFs to hiPSCs
(A) CFNShet-3 and CFNShemi-1 hiPSCs
possess the EFNB1c.712delGmutation compared
with wt-3 hiPSCs. See also Figure S1A.
(B) wt-3, CFNShet-3, and CFNShemi-1
hiPSCs possess differentiation potential to
ectoderm (bIII-tubulin), endoderm (a-fe-
toprotein, AFP), and mesoderm (muscle
actin). Samples were counterstained with
DAPI (blue). Scale bars, 20 mm. See also
Figure S1C.
(C) wt-3, CFNShet-3, and CFNShemi-1
hiPSCs express the endogenous pluripo-
tency markers OCT4, SOX2, NANOG, TRA-1-
60, and TRA-1-81. TRA-1-60- and TRA-1-81-
labeled samples were counterstained with
DAPI (blue). Scale bars, 20 mm. See also
Figure S1D.are induced at the neural plate border, delaminate, and
migrate ventrolaterally to populate the craniofacial struc-
tures and contribute to skeletal, connective, neural, and
vascular tissues. In mice, Ephrin-B1-mediated cell segrega-
tion occurs in the NE prior to NCC emigration (O’Neill
et al., 2016). We therefore reasoned that NE cells are a
good model for testing whether cell segregation occurs
in CFNS, and we began by differentiating CFNS and con-
trol hiPSCs to human neuroepithelial (hNE) cells. We
adapted a monolayer protocol that uses dual-SMAD
inhibition to improve neural differentiation efficiency
through inhibition of activin and nodal signaling (Cham-
bers et al., 2009). All hNE cells, regardless of genotype, had
neuroepithelial morphology and expressed the neural
progenitor cell markers PAX6, SOX1, and OTX2 (Fig-
ure 2A). These data indicate that CFNS patient hiPSCs
are able to differentiate into hNE cells independently of
EPHRIN-B1 expression. hNE cells of all genotypes, but
not hiPSCs, expressed EFNB1 mRNA (Figure 2B), and
over the course of differentiation to hNE cells, expression
of mRNA transcripts of both EFNB1 and PAX6 increased in
a similar manner in cells of each genotype (Figure 2C).
hNE cells of all three genotypes expressed EFNB2, a closely
related B-type ephrin, as well as EPHB2 and EPHB3,signaling partners of EPHRIN-B1 that are involved in
craniofacial development (Orioli et al., 1996) (Figures
S2A–S2C). Wild-type hNE cells expressed EPHRIN-B1 pro-
tein, whereas CFNShet andCFNShemi EFNB1mutant hNE
cells did not (Figure 2D).
EPHRIN-B1 Mosaicism Results in Cell Segregation in
CFNS hNE Cells
To model EFNB1 mosaicism and determine whether it
results in segregation, we generated mixed cultures of fluo-
rescently labeled hNE cells of different genotypes at a 1:1
ratio (Supplemental Experimental Procedures). Control
mixed cultures in which all cells expressed EPHRIN-B1
(wt-3 +wt-3, N = 11/11 trials) or inwhich no cells expressed
EPHRIN-B1 (CFNShet-3 + CFNShet-3, N = 7/7 trials;
CFNShemi-1 + CFNShemi-1, N = 4/4 trials) resulted in
hNE cells commingling freely, with no notable segregation
after 48 hr (Figures 3A–3C). However, in hNE cell popula-
tions mosaic for EPHRIN-B1 expression, EPHRIN-B1-ex-
pressing cells segregated dramatically from EPHRIN-B1
non-expressing cells, forming distinct boundaries between
the two different cell types by 48 hr (Figures 3D and 3E)
(wt-3 + CFNShet-3, N = 10/10 trials; wt-3 + CFNShemi-1,
N = 4/4 trials). To ensure that this segregation dependedStem Cell Reports j Vol. 8 j 529–537 j March 14, 2017 531
Figure 2. Differentiation and Characterization of hNE Cells from hiPSCs
(A) Immunostaining reveals that wt-3, CFNShet-3, and CFNShemi-1 hNE cells express the hNE cell markers PAX6, SOX1, and OTX2. Scale
bars, 50 mm.
(B) EFNB1 mRNA expression (normalized to GAPDH mRNA expression) in hiPSCs and wild-type, CFNShet, and CFNShemi hNE cells. Numbers
following underscores represent separate hNE differentiations. Error bars represent the SD of n = 3 technical replicate qRT-PCR reactions
per hiPSC or hNE line. See also Figure S2.
(C) Relative EFNB1 and PAX6 expression (normalized to GAPDH expression) increase over the course of hNE cell differentiation of wt-3,
CFNShet-3, and CFNShemi-1 hiPSCs. Error bars represent the SD of n = 3 technical replicate qRT-PCR reactions per condition. Data shown are
one of n = 2 biological replicates of each wt-3 and CFNShet-3 or one of n = 3 biological replicates of CFNShemi-1 (n = 2) and CFNShemi-3
(n = 1).
(D) Immunoblotting reveals expression of EPHRIN-B1 protein in wild-type but not CFNShet or CFNShemi hNE cells or in hiPSCs of any
genotype.on EPHRIN-B1 expression and not on differences between
independent hNE cell lines, we mixed hNE lines derived
from different hiPSC lines of the same genotype and also
observed intermixing of cells (wt-3 + wt-2, Figure 3F;
CFNShet-3+CFNShet-1, Figure 3G) (N = 3/3 trials, each con-
dition). Further, mixing hNE lines derived from different
genotypes lacking EPHRIN-B1 expression (CFNShet-3 +
CFNShemi-1, N = 3/3 trials) did not result in cell segrega-
tion (Figure 3H), demonstrating that hNE cells segregate532 Stem Cell Reports j Vol. 8 j 529–537 j March 14, 2017based on the presence or absence of EPHRIN-B1 expression
and not some other factor associated with individual
variability.
To observe the process of cell segregation over time, we
used live cell imaging to capture the first 25 hr after cell
mixing in both mosaic and EPHRIN-B1 non-expressing
cell mixtures. Both cell mixtures were intermingled at
time of mixing (t = 0, Figures S3A and S3G). Cells in both
mixtures continued to interact with each other over time,
Figure 3. Robust Cell Segregation in Neuroepithelial Cells Mosaic for EPHRIN-B1 Expression
(A–C) Mixing two populations of wild-type EPHRIN-B1 expressing hNE cells (A), two populations of CFNShet hNE cells not expressing
EPHRIN-B1 (B), or two populations of CFNShemi hNE cells not expressing EPHRIN-B1 (C) results in cell intermingling over 48 hr.
(D and E) Cell mixing to generate cultures mosaic for EPHRIN-B1 expression (wt-3 + CFNShet-3 (D); wt-3 + CFNShemi-1 (E)) results in robust
segregation of EPHRIN-B1 expressing and non-expressing hNE cells over 48 hr. See also Figure S3.
(F–H) Mixing two different wild-type (EPHRIN-B1 expressing) hNE cell lines (wt-3 + wt-2) (F), two different CFNShet (EPHRIN-B1
non-expressing) hNE cell lines (CFNShet-3 + CFNShet-1) (G), or two EPHRIN-B1 non-expressing hNE cell lines of different genotypes
(CFNShet-3 + CFNShemi-1) (H) results in cell intermingling without cell segregation. Adjustments to gamma were made to better visualize
independent cell populations.
Scale bars, 50 mm.and EPHRIN-B1 non-expressing mixtures remained freely
commingled at each time point (Figures S3B–S3E). How-
ever, the EPHRIN-B1 mosaic population of cells segregated
progressively over 25 hr (Figures S3H–S3L), indicating that
segregation is a continuous process that occurs over time.
These data provide evidence that EPHRIN-B1-mediated
cell segregation can occur in human CFNS.DISCUSSION
Here, we have generated an hiPSC model of a human
craniofacial condition and have used it to address an
outstanding question: does mosaicism for EFNB1 expres-sion result in cell segregation in human CFNS? The
c.712delG mutation found in this CFNS family occurred
50 to the transmembrane domain-encoding region of
EFNB1, and we found that EFNB1 mutant hNE cells did
not express EPHRIN-B1, indicating that this mutation re-
sults in an unstable EPHRIN-B1 protein and most likely
null loss of function. To enable us to model CFNS, it was
essential that loss of EFNB1 function not prevent CFNS pa-
tient-derived HDFs from undergoing reprogramming to
hiPSCs. We did not observe differences in reprogramming
ability between EFNB1 mutant and control HDFs, leading
us to conclude that EPHRIN-B1 expression is not necessary
for reprogramming. Further, we found that both control
and CFNS hiPSCs possessed differentiation potential toStem Cell Reports j Vol. 8 j 529–537 j March 14, 2017 533
all three germ layers; loss of EPHRIN-B1 expression does
not apparently prevent differentiation. This is consistent
with our qRT-PCR data demonstrating that transcripts of
EFNB1 and several other Eph/ephrin signaling family
members are expressed at very low levels in hiPSCs relative
to hNE cells, suggesting that these signalingmoleculesmay
not play critical roles in hiPSCs.
Previous human genetic studies have indicated that
mosaicism for EFNB1 mutation is central to CFNS pathol-
ogy, a phenomenon termed cellular interference suggested
to result in cell segregation based on evidence from model
organisms (Compagni et al., 2003; Twigg et al., 2004, 2006,
2013; Wieacker and Wieland, 2005; Wieland et al., 2004).
Whether cell segregation occurs in CFNS, however, and
in what cell types, was not known. Based on evidence of
cell segregation in the neural plate NE in Efnb1+/ mice
(O’Neill et al., 2016), we differentiated hiPSCs to hNE cells
to address this question.
Both wild-type and CFNS patient-derived hNE cells ex-
pressed neural stem cell markers and several members of
the Eph/ephrin gene family, including EFNB1. Expression
of EFNB1 varied between hNE lines, as well as between
independent differentiations of the same hiPSC line, indi-
cating that there was inherent variability in the differenti-
ations. Consistently, however, hNE cells expressed higher
levels of EFNB1 than hiPSCs, indicating that increased
EFNB1 expression is a characteristic of the hNE cell type.
In addition, EFNB1 expression decreased as hNE cells
were maintained over time, suggesting that higher levels
of EFNB1 expression may mark a progenitor stage in the
differentiation program.
As hiPSCs are clonally derived cell lines, CFNShet hNE
lines are not mosaic for EFNB1 expression, necessitating
a different approach to model cellular interference.
Upon mixing wild-type and EPHRIN-B1 non-expressing
hNE cells to generate EPHRIN-B1 mosaicism, the
EPHRIN-B1 expressing and non-expressing cells segre-
gated to form ectopic boundaries in culture. This robust
segregation occurred in mosaic mixtures of wild-type +
CFNShet cells and wild-type + CFNShemi cells, but not
inmixtures of two different populations of EPHRIN-B1 ex-
pressing cells, or two different populations of EPHRIN-B1
non-expressing cells, even if these two populations were
derived from different hiPSC lines. We therefore conclude
that segregation is not an effect of mixing different
hNE lines, but rather an effect of mosaicism for EPHRIN-
B1 expression, and that cellular interference through
EPHRIN-B1-mediated cell segregation occurs in CFNS
cells. This finding informs our understanding of the
etiology of CFNS and indicates that cell segregation con-
tributes to cellular interference. How cell segregation leads
to more severe disease phenotypes is not yet clear;
the hiPSC model we have developed is a highly relevant534 Stem Cell Reports j Vol. 8 j 529–537 j March 14, 2017system in which to answer remaining questions about
CFNS pathology.
An hiPSC model is an important resource because pa-
tient cells can be differentiated into multiple disease-rele-
vant cell types, overcoming the challenge of isolating
primary cells from patients. It is notable that cell segrega-
tion occurs in the neuroepithelium in models of CFNS;
recent studies have indicated that Treacher Collins syn-
drome, another neurocristopathy, also exhibits cellular
defects originating in the neuroepithelium and ongoing
in the NCC (Jones et al., 2008). Our hiPSC model of
CFNS will facilitate further studies of cell segregation,
such as investigatingwhether it occurs in hNCCs and their
descendants. This will contribute to a better understand-
ing of the developmental timing of CFNS etiology and
will provide the ability to study aspects of the disease
that are less well understood. For example, mutations in
EFNB1 that cause CFNS are responsible for approximately
7% of cases of craniosynostosis in which a genetic cause is
known (Johnson and Wilkie, 2011), and studies in mice
have demonstrated that suture boundary formation is
regulated by A-type Eph/ephrin signaling (Merrill et al.,
2006; Ting et al., 2009). However, how EPHRIN-B1 affects
boundary formation and maintenance at the suture is un-
known, because EFNB1 mutant mice do not exhibit cra-
niosynostosis. Further, in CFNS, other organ systems not
derived from NCCs are also affected; patients exhibit
limb anomalies and defects of the axial skeleton that
may be attributable to cell segregation (Compagni et al.,
2003; Davy et al., 2004, 2006). Differentiation of hiPSCs
into these various cell types is a method for testing the
importance of EPH/EPHRIN-mediated cell segregation in
various tissues.
hiPSC models of congenital craniofacial disease will also
facilitate targeted molecular therapies for these disorders.
As we have shown that cell segregation resulting from
EPHRIN-B1 mosaicism occurs in human CFNS cells, thera-
peutic benefits may be derived from preventing segrega-
tion. Additional research to determine the mechanism by
which hNE cell segregation leads to craniofacial pheno-
types in CFNS patients is likely to identify molecular candi-
dates that could be targeted to achieve this goal. A human
model system of EPHRIN-B1-mediated cell segregation
could then serve as a high-throughput system for testing
candidate therapeutic molecules. Finally, this CFNS hiPSC
model system may encourage the use of hiPSC-based sys-
tems tomodel structural aspects of other congenital cranio-
facial anomalies in which self-organization of cells may
play a role. Such studies have the potential to inform ther-
apeutic approaches for congenital craniofacial anomalies,
as well as to increase our understanding of cell self-orga-
nizing properties to facilitate tissue engineering and cell
replacement therapies for patients with these disorders.
EXPERIMENTAL PROCEDURES
hiPSC Generation, Culture, and Characterization
All human tissue collection, stem cell studies, procedures, and
written consents were approved by the University of California,
San Francisco (UCSF) Committee on Human Research and the
UCSF Gamete, Embryo, and Stem Cell Research Committee.
Prior to their inclusion in this study, written informed consent
was obtained from all participants or from their parents.
CFNS and control hiPSCs were established from primary
human fibroblast cultures from each subject (Byrne et al.,
2009) using episomal reprogramming (Bershteyn et al., 2014;
Okita et al., 2011). hiPSC lines were genetically characterized
using G-banded karyotype analysis (WiCell Research Institute)
and sequencing of EFNB1 (SeqWright). hiPSCs were also
assayed for episomal plasmid integration and for relative
inactivation of each X chromosome with the HUMAR assay
(Kiedrowski et al., 2011). See also the Supplemental Experi-
mental Procedures.
hNE Cell Differentiation
Neural inductions were performed using a modified monolayer
dual-SMAD inhibition protocol (Chambers et al., 2009) with
STEMdiff Neural Induction Medium (STEMCELL Technologies)
containing 10 mM SB-431542 (Santa Cruz Biotechnology) and
5 mM DMH1 (Sigma). See also the Supplemental Experimental
Procedures.
Immunocytochemistry and Immunoblotting
For immunocytochemistry, cells were plated on Matrigel-coated
glass coverslips. For immunoblotting, cells were lysed in NP-40
lysis buffer containing protease and phosphatase inhibitors. Both
procedures were performed using standard protocols. See also the
Supplemental Experimental Procedures.
qRT-PCR of hiPSCs and Neuroepithelial Cells
Total RNA was extracted from cells using TRIzol (Life Technolo-
gies). RNA was reverse transcribed using a SuperScript II First-
Strand Synthesis System for RT-PCR (Life Technologies). qRT-PCR
was performed using iTaq Universal SYBR Green and a CFX96
Real Time System (Bio-Rad), with primer pairs that span exon-
intron boundaries (see Supplemental Experimental Procedures
for primer sequences).
Statistics
For analysis of qRT-PCR data, GraphPad Prism 6 was used to plot
mean expression ± SD of technical replicate reactions, indicated
by error bars. Biological replicates (different hiPSC lines or different
hNE differentiations), if applicable, are shown as separate bars on
the graph.
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